Certolizumab pegol for the treatment of axial spondyloarthritis: 4-year outcomes from the RAPID-axSpA trial

M. Breban, D. Van Der Heijde, M. Dougados, R. Landewé, J. Sieper, W. Maksymowych, M. Rudwaleit, F. Van den bosch, J. Braun, P. J. Mease, O. Davies, B. HŒpken, L. Peterson, A. Deodhar

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Certolizumab pegol for the treatment of axial spondyloarthritis: 4-year outcomes from the RAPID-axSpA trial'. Together they form a unique fingerprint.